Prenatal diagnosis of Myhre syndrome with a heterozygous pathogenic variant in SMAD4 gene presented with thick nuchal translucency and cardiac abnormalities
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6414 ↗Kurz gefasst
Fallbericht in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Pui Wah Hui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Queen Mary Hospital, Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Intellectual Disability, Heart Defects, Congenital, Pericardial Effusion. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Prenatal testing was performed in a 39‐year‐old Chinese pregnant woman referred for increased nuchal translucency measuring 5.7 mm. Non‐invasive prenatal testing and SNP array study on amniotic fluid samples were normal. Whole exome sequencing (WES) was initiated further as the fetus had pericardial effusion of 1.2 mm, thickened myocardium over the right ventricular lateral wall and aberrant right subclavian artery. A detailed fetal echocardiogram also revealed persistent left superior vena cava and dilated coronary sinus at 20 weeks. From whole exome sequencing of the trio, a de novo heterozygous variant NM_005359.5( SMAD4 ): c.1499T>C (p.Ile500Thr) was detected. This pathogenic variant has been reported in the postnatal case cohort of Myhre syndrome. This condition is characterized by facial dysmorphism, intellectual disability, hearing loss, skeletal abnormalities and potential life threatening respiratory or cardiovascular manifestations. Termination of pregnancy was performed at 23 weeks. Small chins, pre‐axial polydactyly, brachydactyly and clinodactyly were noted in the abortus. Ultrasound findings of increased nuchal translucency, thickened myocardium and pericardial effusion prompted further genetic evaluation for the prenatal diagnosis of Myhre syndrome by whole exome sequencing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Queen Mary Hospital, Hong Kong, Hong Kong.
- Department of Health, Clinical Genetic Service, Hong Kong, Hong Kong.
- Prenatal Diagnostic Laboratory, Tsan Yuk Hospital, Hong Kong, Hong Kong.
- Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, Hong Kong.
ORCID-Profile: Pui Wah Hui, Yin Kwan Mok
Zitieren
APA
Hui, P. W., Mok, Y. K., Luk, H. M., Au, S. L. K., Lau, E. Y. T., Chung, B., & Kan, A. S. Y. (2023). Prenatal diagnosis of Myhre syndrome with a heterozygous pathogenic variant in SMAD4 gene presented with thick nuchal translucency and cardiac abnormalities. Prenatal Diagnosis. https://doi.org/10.1002/pd.6414
Vancouver
Hui PW, Mok YK, Luk HM, Au SLK, Lau EYT, Chung B, et al. Prenatal diagnosis of Myhre syndrome with a heterozygous pathogenic variant in SMAD4 gene presented with thick nuchal translucency and cardiac abnormalities. Prenatal Diagnosis. 2023. doi:10.1002/pd.6414
BibTeX
@article{Hui2023,
author = {Hui, Pui Wah and Mok, Yin Kwan and Luk, Ho Ming and Au, Sandy Leung Kuen and Lau, Eunice Yuen Ting and Chung, Brian and Kan, Anita Sik Yau},
title = {Prenatal diagnosis of Myhre syndrome with a heterozygous pathogenic variant in SMAD4 gene presented with thick nuchal translucency and cardiac abnormalities},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6414}
}
EUVIMED